ACE and heart failure: The usage of β-receptor blocker and angiotensin converting enzyme inhibitor (ACEI) can lead to decrease of hospitalization in heart failure patients but no significant decline of morbidity and mortality of heart failure (Liu et al., 2022; Lv et al., 2022; Pan et al., 2022).